|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 74.49 USD | -1.19% |
|
-4.99% | -1.94% |
| 07-07 | RBC Capital Adjusts PTC Therapeutics Price Target to $85 From $82, Maintains Sector Perform Rating | MT |
| 06-28 | PTC Therapeutics, Inc.(NasdaqGS:PTCT) added to Russell 2000 Value-Defensive Index | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.19% | -4.99% | -8.68% | +15.40% | -1.94% | +51.13% | +81.99% | +94.80% | +1,147.74% | 6.18B | |
| -0.87% | +4.04% | -1.62% | +42.15% | +12.59% | +58.60% | +163.92% | +393.22% | +1,359.79% | 1,079B | |
| -0.45% | +3.87% | +2.72% | +16.79% | +28.31% | +57.95% | +52.18% | +54.22% | +112.03% | 640B | |
| +0.04% | +3.95% | +3.54% | +29.14% | +15.23% | +37.69% | +74.54% | +121.50% | +297.55% | 465B | |
| -0.94% | +3.12% | +8.29% | +13.19% | +9.81% | +38.83% | +33.19% | +2.87% | +46.86% | 353B | |
| -0.59% | +1.44% | +2.31% | +11.73% | +18.16% | +36.29% | +42.20% | +54.39% | +62.59% | 301B | |
| -0.91% | +3.01% | -7.30% | -6.29% | -5.22% | +13.67% | +16.84% | +58.08% | +157.99% | 271B | |
| -0.65% | +5.17% | +7.07% | +23.73% | +3.57% | +3.65% | -38.32% | +16.16% | +76.87% | 228B | |
| -1.39% | +5.90% | +7.51% | +14.68% | +18.43% | +27.70% | +64.00% | +59.88% | +125.33% | 209B | |
| -1.18% | +1.83% | +5.07% | +3.02% | +8.14% | +16.20% | +72.69% | +90.08% | +67.02% | 165B | |
| -0.40% | +1.33% | +3.20% | -4.23% | +1.00% | +3.50% | -30.27% | -41.22% | -31.82% | 143B | |
| -0.79% | +3.85% | +7.75% | +9.57% | +16.98% | +34.66% | +2.75% | -7.41% | -15.65% | 129B | |
| -1.44% | +2.28% | -3.27% | +14.20% | +6.61% | +3.19% | +36.51% | +141.21% | +398.28% | 123B | |
| -3.32% | +0.98% | +2.70% | -3.40% | -6.78% | -9.83% | -20.58% | -11.25% | +1.10% | 109B | |
| -1.53% | +4.38% | +0.40% | +3.14% | +9.02% | +36.00% | +43.65% | +12.23% | -6.43% | 106B | |
| +0.03% | -1.96% | -6.15% | -12.88% | -14.22% | -4.52% | +67.12% | +75.90% | +449.56% | 70.98B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| -2.21% | +3.87% | +10.92% | +8.50% | +18.26% | +33.10% | +31.72% | +55.30% | +19.12% | 56.98B | |
| +0.95% | +4.16% | -0.60% | +26.47% | +30.02% | +70.61% | -9.45% | -4.31% | -50.06% | 53.32B | |
| +1.13% | -2.71% | +1.81% | -2.00% | -9.54% | -15.53% | +9.87% | -2.21% | +232.58% | 52.55B | |
| Average | -0.68% | +2.94% | +1.88% | +10.68% | +8.34% | +25.94% | +36.56% | +61.23% | +234.23% | 231.19B | |
| Weighted average by Cap. | -0.66% | +4.34% | +1.95% | +19.41% | +12.45% | +36.92% | +65.90% | +131.35% | +417.01% |
- Stock Market
- Stocks
- PTCT Stock
- Sector PTC Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
